Clinical Trial Update: Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing nab-paclitaxel as second-line therapy for locally advanced or metastatic squamous cell carcinoma of the lung is ongoing; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Squamous Cell Carcinoma of Lung | Phase 2 | Status: UNKNOWN